Open the map

IQVIA HoldingsIQV

CDMO & pharma manufacturing · NYSE · USA

$258.88
Up 0.3% todayClose

Up 14.5% this year and +35.4% since June 26, ahead of the life science sector at +10.7%. IQVIA Holdings supplies 8 mapped companies.

Market cap
$42.2B
This year
+14.5%
1 year
+28.5%
P/E
30.7
P/S
2.5
P/B
6.8

Price vs the life science sector

since Jun 26IQVLife science sector, equal weight
IQVIA Holdings (IQV) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. IQV: +35.4% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%+30%+40%Jun 26AugSepOct 8IQV +35.4%Sector +10.7% IQVIA Holdings (IQV) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. IQV: +35.4% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+20%+40%Jun 26AugSepOct 8IQV+35.4%Sector+10.7%

Supply chain

8 customers
SUPPLIERS →→ CUSTOMERSNone mappedPfizer (PFE)PFEPfizer−0.6%Merck & Co. (MRK)MRKMerck & Co.−0.3%Gilead Sciences (GILD)GILDGilead Sciences+0.2%Biogen (BIIB)BIIBBiogen−1.7%United Therapeutics (UTHR)UTHRUnited Therapeutics−2.2%Neurocrine Biosciences (NBIX)NBIXNeurocrine Bioscien…−1.5%Eli Lilly (LLY)LLYEli Lilly−1.6%Amgen (AMGN)AMGNAmgen−1.4%IQVIQVIA Holdings

Customers 8

Open the full chain →

About IQVIA Holdings

Drug companies outsource clinical trials to IQVIA, and many of the same customers buy its health data and analytics. A third arm sells commercial services to the pharmaceutical industry.

Theme exposure

Clinical research & dataClinical researchHealth dataPharma services

Products

  • Clinical trials (CRO)
  • Health data & analytics
  • Commercial pharma services

Competitors

Risks

  • Biotech funding
  • Data privacy regulation

Same segment: CDMO & pharma manufacturing

Contract development and manufacturing of medicines, the industrial backbone behind the drugs. Segment 4 of 8 in the Medicine, pharma & life science value chain.

West Pharmaceutical ServicesWST−0.9%Charles River LaboratoriesCRL−0.8%

Compare IQV

Side by side with the largest companies in the same segment.

IQV vs WSTIQV vs CRL

See where IQVIA Holdings sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →